Results 51 to 60 of about 19,193 (244)
INTRODUCTION The impact of sarcopenia in patients undergoing transjugular intrahepatic portosystemic shunt (TIPSS) insertion for refractory ascites is unknown. METHODS All adult patients who underwent TIPSS insertion for refractory ascites between 2010
Amine Benmassaoud +8 more
semanticscholar +1 more source
Bleeding ectopic varices is an uncommon but life-threatening complication of portal hypertension that requires a high clinical index of suspicion for early diagnosis and management.
Irfan Masood, MD +4 more
doaj +1 more source
Transjugular intrahepatic portosystemic shunt is a percutaneous radiologic‐guided procedure that aims to reduce portal hypertension by creating a shunt between the portal venous system and the hepatic venous system.
A. Horhat +3 more
semanticscholar +1 more source
[Transjugular intrahepatic portosystemic shunt].
The transjugular intrahepatic portosystemic shunt (TIPS) is a relatively new method of creating a portosystemic shunt using a needle, angioplasty balloon catheters and expandable metallic stents. During a 6-month period, the authors have performed TIPS, using the spiral Z-stent--another modification of the Gianturco-Rósch stent--in 13 patients with ...
J, Llevadot González +2 more
+6 more sources
Aszites, Pfortaderthrombose und hepatische Enzephalopathie bei Leberzirrhose: Aktuelle Therapieempfehlungen [PDF]
Treatment of Ascites, Portal Vein Thrombosis and Hepatic Encephalopathy in Patients with Cirrhosis of the Liver Background: Ascites, portal vein thrombosis and hepatic encephalopathy are important complications of cirrhosis of the liver.
Abecasis R +46 more
core +1 more source
To describe the technique and outcomes of mesenteric access under ultrasound guidance to perform portal vein recanalization–transjugular intrahepatic portosystemic shunt (PVR-TIPS). Four patients (3 male: 1 female, mean age: 46.2 years; range 38–64 years)
P. Entezari +3 more
semanticscholar +1 more source
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. [PDF]
Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and mortality.
Abraldes, Juan +29 more
core +4 more sources
The Budd–Chiari syndrome is a heterogeneous group of disorders characterized by obstruction of hepatic venous outflow at any level from the small hepatic veins to the junction of the inferior vena cava with the right atrium. We present two cases of Budd–
Eric López-Méndez +4 more
doaj +1 more source
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis [PDF]
Hepatorenal syndrome (HRS) is a serious complication of end-stage liver disease, occurring mainly in patients with advanced cirrhosis and ascites, who have marked circulatory dysfunction,1 as well as in patients with acute liver failure.2 In spite of its
Angeli P +21 more
core +4 more sources
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG) under
D. Tripathi +14 more
semanticscholar +1 more source

